0001567619-19-017520.txt : 20190823
0001567619-19-017520.hdr.sgml : 20190823
20190823160806
ACCESSION NUMBER: 0001567619-19-017520
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190821
FILED AS OF DATE: 20190823
DATE AS OF CHANGE: 20190823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rousseau Raphael
CENTRAL INDEX KEY: 0001754287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 191049214
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone Oncology, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc1.xml
FORM 4
X0306
4
2019-08-21
0
0001656634
Gritstone Oncology, Inc.
GRTS
0001754287
Rousseau Raphael
C/O GRITSTONE ONCOLOGY, INC.
5858 HORTON STREET, SUITE 210
EMERYVILLE
CA
94608
0
1
0
0
See Remarks
Common Stock
2019-08-21
4
M
0
10000
0.76
A
10000
D
Common Stock
2019-08-21
4
S
0
10000
10.7631
D
0
D
Stock Option (Right to Buy)
0.76
2019-08-21
4
M
0
10000
0
D
2018-04-17
2027-05-17
Common Stock
10000
155326
D
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $10.71 to $10.87 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
The stock option vests and becomes exercisable with respect to 25% of the total number of shares on April 17, 2018. The remaining shares vest and become exercisable in equal monthly installments over the following 36 months.
Executive Vice President and Chief Medical Officer
/s/ Dana B. Johnson, Attorney-in-Fact for Raphael Rousseau
2019-08-23